Rare or Unverified Outcomes Shape Vaccine Safety and Gender Care Debates — The Monitor
Two recent federal actions, including a memo about alleged COVID-19 vaccine deaths and settlements creating…
Two recent federal actions, including a memo about alleged COVID-19 vaccine deaths and settlements creating a “detransition clinic,” show how official actions can present uncertain or uncommon outcomes as representative and lend credibility to narratives that go beyond what evidence supports.
[Sponsored] A webinar sponsored by Verato and scheduled for June 17 from 1 pm to 2 pm ET will explore how a unified identity strategy, spanning patients, providers, and emerging solutions enabling accurate attribution, strengthens interoperability, and ultimately drives VBC success. Register today! The post The Identity Gap Undermining Value-Based Care appeared first on MedCity News.
President Donald Trump, who once declared he had “saved” flavored vapes, grew his stock holdings this year to as much as $1.64 million in tobacco giant Philip Morris. He also had holdings in Altria and a third leading tobacco company, though an apparent discrepancy in his disclosures clouds the extent of his investments. In 2025,…
When health economics emerged as a distinct discipline in the late 1960s, mainstream academic and policy paradigms widely presumed that competitive market mechanisms were structurally incompatible with medical delivery. Influenced by foundational ideas like Kenneth Arrow’s 1963 landmark paper emphasizing the pervasive friction of clinical uncertainty, early experts argued that society had to look almost…
The Digital Medicine Society launched an initiative to help payers and virtual care providers avoid common contract implementation challenges. The post DiMe Launches New Initiative for Virtual-First Care appeared first on MedCity News.
During a panel at HFMA’s annual conference, two healthcare credit analysts said the industry is already fracturing into winners and losers. And with 2030 bringing a perfect storm of demographic pressure, reimbursement cuts and AI disruption, they think window for bold action is closing fast. The post ‘2030 Scares Me to Death’: Credit Analysts’ Urgent…
This budget summary provides an analysis of global health funding amounts provided in the FY 2027 House Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill and accompanying report.
Parabilis Medicines is developing a new type of peptide drug capable of hitting elusive disease targets inside cells. Cancer is the biotech’s initial focus, and the IPO cash will support a lead program zolucatetide, which is in development for a rare type of tumor with limited treatment options. The post Parabilis Medicines’ Quest to Drug…
Officials, environmental health advocates, and skin care industry groups are expressing hope that the Food and Drug Administration’s approval of a sunscreen ingredient on June 9 — after consideration for two decades, and global use for nearly as long — will help restore Americans’ wavering faith in sunscreen. “Bemotrizinol has been used safely in Europe…
The next evolution of patient experience will not be defined by more digital touchpoints. It will be defined by giving nurses and care teams the capacity to be fully present. The post Restoring the Patient-Clinician Relationship to the Center of Care appeared first on MedCity News.